The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo

Merdzhanova, G ; Gout, S ; Keramidas, M ; Edmond, V ; Coll, J-L ; Brambilla, C ; Brambilla, E ; Gazzeri, S ; Eymin, B

Oncogene, 2010-09, Vol.29 (39), p.5392-5403 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível